The abstract is read at the publisher; the summary is JClub's.
DNASE1L3 R206C in systemic sclerosis is linked to higher mortality (HR 1.16, 95% CI 1.02–1.32) in 2366 patients after adjusting for onset age and sex.
- Why it matters: Patients with systemic sclerosis have a well-recognized but incompletely explained susceptibility to pulmonary arterial hypertension, and this work tests whether a heritable DNASE1L3 loss-of-function variant predicts worse outcomes.
- What they did: Using UTHealth Houston, Royal Free Hospital, and Johns Hopkins University cohorts, the study estimated mortality risk and precapillary PH time-to-event from SSc onset with Cox models and meta-analyses.
- The result: In 1170 patients, DNASE1L3 R206C is associated with greater precapillary PH risk (HR 1.69, 95% CI 1.31–2.19) after adjusting for onset age, sex, and ILD, with most precapillary PH cases consistent with WHO Group I PAH.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.